-
Something wrong with this record ?
Clear Cell Neoplasms of Salivary Glands: A Diagnostic Challenge
A. Skalova, I. Leivo, H. Hellquist, RHW. Simpson, V. Vander Poorten, SM. Willems, E. Mosaieby, D. Slouka, A. Ferlito
Language English Country United States
Document type Journal Article, Review
- MeSH
- Carcinoma * pathology MeSH
- Humans MeSH
- Carcinoma, Mucoepidermoid * diagnosis genetics pathology MeSH
- Biomarkers, Tumor genetics MeSH
- Salivary Gland Neoplasms * diagnosis genetics pathology MeSH
- Salivary Glands pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
This review focuses on the heterogenous group of clear cell neoplasms of salivary glands and attempts to identify major differential diagnostic features. Within the head and neck region, clear cells are found most commonly in salivary gland tumors, but may also be seen in tumors of squamous or odontogenic epithelial origin, primary or metastatic carcinomas, benign or malignant melanocytic lesions, or benign or malignant mesenchymal tumors. Clear cells occur fairly commonly among a wide variety of salivary gland neoplasms, but mostly they constitute only a minor component of the tumor cell population. Clear cells represent a major diagnostic feature in two salivary gland neoplasms, epithelial-myoepithelial carcinoma and hyalinizing clear cell carcinoma. In addition, salivary gland neoplasms composed predominantly of clear cells could also include clear cell variants of other salivary neoplasms, such as mucoepidermoid carcinoma and myoepithelial carcinoma, but their tumor type-specific histologic features may only be available in limited nonclear cell areas of the tumor. Diagnosing predominantly clear cell salivary gland tumors is difficult because the immunoprofiles and morphologic features may overlap and the same tumor entity may also have a wide range of other histologic presentations. Many salivary gland tumors are characterized by tumor type-specific genomic alterations, particularly gene fusions of the ETV6 gene in secretory carcinoma, the MYB and MYBL1 genes in adenoid cystic carcinoma, the MAML2 gene in mucoepidermoid carcinoma, the EWSR1 gene in hyalinizing clear cell carcinoma, and others. Thus, along with conventional histopathologic examination and immunoprofiling, molecular and genetic tests may be important in the diagnosis of salivary gland clear cell tumors by demonstrating genetic alterations specific to them.
Department of Anatomical Pathology University of Calgary Calgary Alberta Canada
Department of Pathology and Medical Biology University of Groningen Groningen The Netherlands
International Head and Neck Scientific Group Padua Italy
Molecular and Genetic Laboratory Bioptic Laboratory Ltd Plzen Czech Republic
Otorhinolaryngology Faculty of Medicine in Plzen Charles University
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017843
- 003
- CZ-PrNML
- 005
- 20220804134420.0
- 007
- ta
- 008
- 220720s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAP.0000000000000339 $2 doi
- 035 __
- $a (PubMed)35249992
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skalova, Alena $u Departments of Pathology
- 245 10
- $a Clear Cell Neoplasms of Salivary Glands: A Diagnostic Challenge / $c A. Skalova, I. Leivo, H. Hellquist, RHW. Simpson, V. Vander Poorten, SM. Willems, E. Mosaieby, D. Slouka, A. Ferlito
- 520 9_
- $a This review focuses on the heterogenous group of clear cell neoplasms of salivary glands and attempts to identify major differential diagnostic features. Within the head and neck region, clear cells are found most commonly in salivary gland tumors, but may also be seen in tumors of squamous or odontogenic epithelial origin, primary or metastatic carcinomas, benign or malignant melanocytic lesions, or benign or malignant mesenchymal tumors. Clear cells occur fairly commonly among a wide variety of salivary gland neoplasms, but mostly they constitute only a minor component of the tumor cell population. Clear cells represent a major diagnostic feature in two salivary gland neoplasms, epithelial-myoepithelial carcinoma and hyalinizing clear cell carcinoma. In addition, salivary gland neoplasms composed predominantly of clear cells could also include clear cell variants of other salivary neoplasms, such as mucoepidermoid carcinoma and myoepithelial carcinoma, but their tumor type-specific histologic features may only be available in limited nonclear cell areas of the tumor. Diagnosing predominantly clear cell salivary gland tumors is difficult because the immunoprofiles and morphologic features may overlap and the same tumor entity may also have a wide range of other histologic presentations. Many salivary gland tumors are characterized by tumor type-specific genomic alterations, particularly gene fusions of the ETV6 gene in secretory carcinoma, the MYB and MYBL1 genes in adenoid cystic carcinoma, the MAML2 gene in mucoepidermoid carcinoma, the EWSR1 gene in hyalinizing clear cell carcinoma, and others. Thus, along with conventional histopathologic examination and immunoprofiling, molecular and genetic tests may be important in the diagnosis of salivary gland clear cell tumors by demonstrating genetic alterations specific to them.
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 12
- $a karcinom $x patologie $7 D002277
- 650 12
- $a mukoepidermoidní karcinom $x diagnóza $x genetika $x patologie $7 D018277
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory slinných žláz $x diagnóza $x genetika $x patologie $7 D012468
- 650 _2
- $a slinné žlázy $x patologie $7 D012469
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Leivo, Ilmo $u Institute of Biomedicine, Pathology, University of Turku and Department of Pathology, Turku University Hospital, Turku, Finland
- 700 1_
- $a Hellquist, Henrik $u Epigenetics and Human Disease Laboratory, Department of Biomedical Sciences and Medicine, Algarve Biomedical Center (ABC), University of Algarve, Faro, Portugal
- 700 1_
- $a Simpson, Roderick H W $u Department of Anatomical Pathology, University of Calgary, Calgary, Alberta, Canada
- 700 1_
- $a Vander Poorten, Vincent $u Department of Oncology, Section Head and Neck Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
- 700 1_
- $a Willems, Stefan M $u Department of Pathology and Medical Biology, University of Groningen, Groningen, The Netherlands
- 700 1_
- $a Mosaieby, Elaheh $u Departments of Pathology $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Plzen, Czech Republic
- 700 1_
- $a Slouka, David $u Otorhinolaryngology, Faculty of Medicine in Plzen, Charles University
- 700 1_
- $a Ferlito, Alfio $u International Head and Neck Scientific Group, Padua, Italy
- 773 0_
- $w MED00000158 $t Advances in anatomic pathology $x 1533-4031 $g Roč. 29, č. 4 (2022), s. 217-226
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35249992 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134414 $b ABA008
- 999 __
- $a ok $b bmc $g 1821771 $s 1169086
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 29 $c 4 $d 217-226 $e 20220307 $i 1533-4031 $m Advances in anatomic pathology $n Adv Anat Pathol $x MED00000158
- LZP __
- $a Pubmed-20220720